Drug Profile
Androtriol - Guangzhou Cellprotek Pharmaceutical
Alternative Names: YC-6Latest Information Update: 28 Jan 2020
Price :
$50
*
At a glance
- Originator Guangzhou Cellprotek Pharmaceutical
- Developer Guangzhou Cellprotek Pharmaceutical; Xiuhe Medical Technique
- Class Anti-ischaemics; Neuroprotectants; Phenanthrenes; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Stroke
Most Recent Events
- 28 Jan 2020 No recent reports of development identified for phase-I development in Stroke(In volunteers) in China (IV, Infusion)
- 13 Dec 2017 Chemical structure information added
- 27 Jun 2017 Guangzhou Cellprotek Pharmaceutical has patent protection for androtriol in USA